Lv1
32 积分 2025-03-15 加入
A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
2小时前
已完结
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
1个月前
已完结
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201
1个月前
已完结
Avutometinib and Defactinib: First Approval
1个月前
已完结
Targeting Solvent-Front Mutations for Kinase Drug Discovery: From Structural Basis to Design Strategies
1个月前
已完结
Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective
1个月前
已完结
Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma
1个月前
已关闭
Nonclinical Safety Profile of Sotorasib, a KRASG12C-Specific Covalent Inhibitor for the Treatment of KRAS p.G12C-Mutated Cancer
2个月前
已完结
New drug approvals for 2022: Synthesis and clinical applications
2个月前
已完结
Inavolisib: First Approval
2个月前
已完结
皖公网安备34019202002308
